EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 397 filers reported holding EXELIXIS INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,203,000 | +2.3% | 75,000 | 0.0% | 0.06% | -8.8% |
| Q3 2022 | $1,176,000 | -24.7% | 75,000 | 0.0% | 0.07% | -25.3% |
| Q2 2022 | $1,562,000 | +65.6% | 75,000 | +44.8% | 0.09% | +213.8% |
| Q2 2021 | $943,000 | -37.2% | 51,779 | -22.1% | 0.03% | -32.6% |
| Q1 2021 | $1,501,000 | -61.2% | 66,460 | -66.2% | 0.04% | -94.4% |
| Q4 2018 | $3,870,000 | +118.4% | 196,755 | +96.8% | 0.77% | +107.2% |
| Q3 2018 | $1,772,000 | +100.0% | 100,000 | +150.0% | 0.37% | -28.7% |
| Q1 2018 | $886,000 | -63.6% | 40,000 | -50.0% | 0.52% | -48.6% |
| Q4 2017 | $2,432,000 | +98.4% | 80,000 | +58.1% | 1.02% | +183.6% |
| Q3 2017 | $1,226,000 | – | 50,600 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
| Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
| Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
| Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
| C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
| QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
| Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |